Replimune Group Inc (REPL)
6.95
+0.39
(+5.95%)
USD |
NASDAQ |
May 03, 16:00
6.965
+0.02
(+0.22%)
After-Hours: 20:00
Replimune Group Shareholders Equity (Quarterly): 421.54M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 421.54M |
| September 30, 2023 | 465.17M |
| June 30, 2023 | 514.03M |
| March 31, 2023 | 555.29M |
| December 31, 2022 | 595.34M |
| September 30, 2022 | 384.07M |
| June 30, 2022 | 410.26M |
| March 31, 2022 | 411.23M |
| December 31, 2021 | 437.51M |
| September 30, 2021 | 457.41M |
| June 30, 2021 | 479.02M |
| March 31, 2021 | 498.73M |
| Date | Value |
|---|---|
| December 31, 2020 | 516.20M |
| September 30, 2020 | 261.39M |
| June 30, 2020 | 277.81M |
| March 31, 2020 | 183.72M |
| December 31, 2019 | 197.56M |
| September 30, 2019 | 120.64M |
| June 30, 2019 | 130.15M |
| March 31, 2019 | 137.86M |
| December 31, 2018 | 143.24M |
| September 30, 2018 | 150.04M |
| June 30, 2018 | -38.70M |
| March 31, 2018 | -28.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
120.64M
Minimum
Sep 2019
595.34M
Maximum
Dec 2022
385.11M
Average
421.54M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Esperion Therapeutics Inc | -454.99M |
| Gossamer Bio Inc | 62.77M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 532.93M |
| Total Liabilities (Quarterly) | 111.39M |